ICMR had permitted off-label use of convalescent plasma to treat COVID-19 patients in its revised guidelines on April 22, but now they have pulled it back. However, there is a lot of confusion regarding the line of treatment to be followed in treating COVID-19 patients. 'Line of Treatment'In October 2020, Remdesivir became the first drug approved by the Food and Drug Administration (FDA) to treat COVID-19. To date, it is still the only COVID-19 treatment that's been approved by the FDA. Oxygen therapy and supportive care are still the main forms of therapy for SARS-CoV-2 pneumonia until suitable anti-infective therapies become available.

Source: dna May 18, 2021 07:18 UTC